首 页
医药产品
医保药品
中标目录
医药招标
数据中心
医学资料
医药新闻
医药展会
OTC药品
保健品
医疗器械
处方药
专科药
中医药
器械中标目录
药品批发行情
求购信息
医药下载
药价简讯
当前位置:药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目收费,不能显示细节,电话15274084725)
药品名称:
商品名称:
药品NDC:
上市日期:
-
格式:2020-5-3
注册申请号:
市场分类:
不限
ANDA
BLA
NDA
EMERGENCY USE AUTHORIZATION
NDA AUTHORIZED GENERIC
OTC MONOGRAPH FINAL
OTC MONOGRAPH NOT FINAL
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
UNAPPROVED DRUG OTHER
UNAPPROVED HOMEOPATHIC
UNAPPROVED MEDICAL GAS
活性成分:
持证企业:
美国药品NDC(国家药品编码)与药品说明书数据库
美国NDC未完成药物数据库文件
美国NDC复合药物数据库文件
美国NDC数据库排除药物数据库文件
 美国NDC未完成药物数据库文件19583条(本栏目收费,不能显示细节,电话15274084725)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
Insulin lispro
DRUG FOR FURTHER PROCESSING
0002-1455
Eli Lilly and Company
2017/6/6 0:00:00
INSULIN LI
DRUG FOR FURTHER PROCESSING
100
0002-1455_
Olanzapine pamoate
DRUG FOR FURTHER PROCESSING
0002-1606
Eli Lilly and Company
2009/12/11 0:00:00
OLANZAPINE
DRUG FOR FURTHER PROCESSING
210
0002-1606_
Olanzapine pamoate
DRUG FOR FURTHER PROCESSING
0002-2003
Eli Lilly and Company
2009/12/11 0:00:00
OLANZAPINE
DRUG FOR FURTHER PROCESSING
300
0002-2003_
Insulin human
DRUG FOR FURTHER PROCESSING
0002-2045
Eli Lilly and Company
2013/11/7 0:00:00
INSULIN HU
DRUG FOR FURTHER PROCESSING
100
0002-2045_
Pemetrexed disodium
DRUG FOR FURTHER PROCESSING
0002-2059
Eli Lilly and Company
2008/1/15 0:00:00
PEMETREXED
DRUG FOR FURTHER PROCESSING
100
0002-2059_
Pemetrexed disodium
DRUG FOR FURTHER PROCESSING
0002-2060
Eli Lilly and Company
2004/2/13 0:00:00
PEMETREXED
DRUG FOR FURTHER PROCESSING
500
0002-2060_
ramucirumab
DRUG FOR FURTHER PROCESSING
0002-2129
Eli Lilly and Company
2014/4/21 0:00:00
RAMUCIRUMA
DRUG FOR FURTHER PROCESSING
10
0002-2129_
Olanzapine pamoate
DRUG FOR FURTHER PROCESSING
0002-2344
Eli Lilly and Company
2009/12/11 0:00:00
OLANZAPINE
DRUG FOR FURTHER PROCESSING
405
0002-2344_
galcanezumab-gnlm
DRUG FOR FURTHER PROCESSING
0002-2377
Eli Lilly and Company
2018/9/27 0:00:00
GALCANEZUM
DRUG FOR FURTHER PROCESSING
120
0002-2377_
necitumumab
DRUG FOR FURTHER PROCESSING
0002-2412
Eli Lilly and Company
2015/11/24 0:00:00
NECITUMUMA
DRUG FOR FURTHER PROCESSING
16
0002-2412_
Insulin lispro-aabc
DRUG FOR FURTHER PROCESSING
0002-2415
Eli Lilly and Company
2020/6/15 0:00:00
INSULIN LI
DRUG FOR FURTHER PROCESSING
100
0002-2415_
ramucirumab
DRUG FOR FURTHER PROCESSING
0002-2477
Eli Lilly and Company
2014/4/21 0:00:00
RAMUCIRUMA
DRUG FOR FURTHER PROCESSING
10
0002-2477_
Insulin lispro-aabc
DRUG FOR FURTHER PROCESSING
0002-2479
Eli Lilly and Company
2020/6/15 0:00:00
INSULIN LI
DRUG FOR FURTHER PROCESSING
100
0002-2479_
Insulin lispro
DRUG FOR FURTHER PROCESSING
0002-2499
Eli Lilly and Company
2017/6/6 0:00:00
INSULIN LI
DRUG FOR FURTHER PROCESSING
100
0002-2499_
Insulin lispro-aabc
DRUG FOR FURTHER PROCESSING
0002-2509
Eli Lilly and Company
2020/6/15 0:00:00
INSULIN LI
DRUG FOR FURTHER PROCESSING
100
0002-2509_
Insulin human
DRUG FOR FURTHER PROCESSING
0002-2510
Eli Lilly and Company
1989/6/26 0:00:00
INSULIN HU
DRUG FOR FURTHER PROCESSING
100
0002-2510_
Insulin lispro-aabc
DRUG FOR FURTHER PROCESSING
0002-2572
Eli Lilly and Company
2020/6/15 0:00:00
INSULIN LI
DRUG FOR FURTHER PROCESSING
100
0002-2572_
Insulin lispro
DRUG FOR FURTHER PROCESSING
0002-2576
Eli Lilly and Company
1996/6/14 0:00:00
INSULIN LI
DRUG FOR FURTHER PROCESSING
100
0002-2576_
Insulin lispro-aabc
DRUG FOR FURTHER PROCESSING
0002-2578
Eli Lilly and Company
2020/6/15 0:00:00
INSULIN LI
DRUG FOR FURTHER PROCESSING
200
0002-2578_
galcanezumab-gnlm
DRUG FOR FURTHER PROCESSING
0002-3115
Eli Lilly and Company
2019/6/4 0:00:00
GALCANEZUM
DRUG FOR FURTHER PROCESSING
100
0002-3115_
1
(current)
2
(current)
3
(current)
4
(current)
5
(current)
6
(current)
7
(current)
8
(current)
9
(current)
10
(current)
(current)
末页
(current)
网站地图
-
网站开发
-
网站简介
-
会员服务
-
法律声明
-
联系我们
-
药品招商频道
-
药品信息排行
-
2018年版国家基本药物目录
-
意见反馈
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:
国家药品监督管理局
|
国家中医药管理局
|
SDA药品评审中心
|
医加医疗器械
|
膏药生产厂家
|
爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究 客服热线:0575-83552251 / 13754370441 QQ客服:
浙ICP备16010490号-2
增值电信业务经营许可证:
浙B2-20220931
互联网药品信息服务资格证书编号:
(浙)-经营性2023-0215
浙公网安备:33068302000535
医药代理商群1:
医药代理商群2:
医药代理商群3: